Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03628924
Brief Title: A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) (NOVA)

First Submitted : August 9, 2018
First Submitted that Met QC Criteria : August 9, 2018
First Posted : August 14, 2018

Last Update Submitted that Met QC Criteria : February 18, 2020
Last Update Posted : February 19, 2020